NEO News and Press, NeoGenomics Inc.

2024-07-12 11:24:12 ET More on etc. Riskified: Strong Value Proposition, Large TAM; Multiple Expansion Likely Downgrade Alert: AMD's Uphill Battle Against Nvidia Is Getting Much Steeper Redwire: Capitalizing On The Space Economy Hollysys Automation ticks high...

2024-07-12 11:24:12 ET More on etc. Riskified: Strong Value Proposition, Large TAM; Multiple Expansion Likely Downgrade Alert: AMD's Uphill Battle Against Nvidia Is Getting Much Steeper Redwire: Capitalizing On The Space Economy Hollysys Automation ticks high...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...

2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...

2024-06-06 07:00:00 ET Summary GeneDx Holdings Corp. focuses on delivering precise medical diagnostic outcomes through its genomic expertise and rare disease dataset. Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) are key revenue drivers, growing 96% in the first q...

2024-06-01 19:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093)...

2024-04-30 14:11:03 ET NeoGenomics, Inc. (NEO) Q1 2024 Earnings Conference Call April 30, 2024, 08:30 AM ET Company Participants Kendra Sweeney - VP of IR Chris Smith - CEO Jeff Sherman - CFO Warren Stone - Chief Commercial Officer Melody Harris - Chief O...

2024-04-30 07:39:55 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics announces senior leadership promotions Seeking Alpha’s Quant Rating on NeoGenomics Read the full article on Seeking Alpha For further details se...